Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes

Autor: Gertjan J.L. Kaspers, Charlotte J. Dommering, Annette C. Moll, Annemarie H. van der Hout, Najim Ameziane, Saskia E. van Mil, Josephine C. Dorsman, Yne de Vries, Jacqueline Cloos, Hanne Meijers-Heijboer, Hein te Riele, Maarten P.G. Massink, Berber M. Mol, Irsan E. Kooi
Přispěvatelé: Human genetics, CCA - Cancer biology, Pediatric surgery, Ophthalmology, EMGO - Quality of care, ICaR - Circulation and metabolism, Hematology laboratory
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Scientific Reports
Kooi, I E, Mol, B M, Massink, M P G, Ameziane, N, Meijers-Heijboer, H, Dommering, C J, van Mil, S E, de Vries, Y, van der Hout, A H, Kaspers, G J L, Moll, A C, te Riele, H, Cloos, J & Dorsman, J C 2016, ' Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes ', Scientific Reports, vol. 6 . https://doi.org/10.1038/srep25264
Scientific Reports, 6:25264. Nature Publishing Group
Scientific Reports, 6. Nature Publishing Group
ISSN: 2045-2322
Popis: Retinoblastoma is a rare childhood cancer initiated by RB1 mutation or MYCN amplification, while additional alterations may be required for tumor development. However, the view on single nucleotide variants is very limited. To better understand oncogenesis, we determined the genomic landscape of retinoblastoma. We performed exome sequencing of 71 retinoblastomas and matched blood DNA. Next, we determined the presence of single nucleotide variants, copy number alterations and viruses. Aside from RB1, recurrent gene mutations were very rare. Only a limited fraction of tumors showed BCOR (7/71, 10%) or CREBBP alterations (3/71, 4%). No evidence was found for the presence of viruses. Instead, specific somatic copy number alterations were more common, particularly in patients diagnosed at later age. Recurrent alterations of chromosomal arms often involved less than one copy, also in highly pure tumor samples, suggesting within-tumor heterogeneity. Our results show that retinoblastoma is among the least mutated cancers and signify the extreme sensitivity of the childhood retina for RB1 loss. We hypothesize that retinoblastomas arising later in retinal development benefit more from subclonal secondary alterations and therefore, these alterations are more selected for in these tumors. Targeted therapy based on these subclonal events might be insufficient for complete tumor control.
Databáze: OpenAIRE